Yousuf Khalifa
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Keratitis | 2 | 2010 | 10 |
Why?
|
Phakic Intraocular Lenses | 2 | 2010 | 3 |
Why?
|
Corneal Diseases | 2 | 2010 | 19 |
Why?
|
Anti-Inflammatory Agents | 4 | 2008 | 80 |
Why?
|
Uveomeningoencephalitic Syndrome | 2 | 2009 | 1 |
Why?
|
Cannabidiol | 4 | 2006 | 2 |
Why?
|
Cataract | 2 | 2010 | 17 |
Why?
|
Lens Implantation, Intraocular | 2 | 2010 | 4 |
Why?
|
Device Removal | 2 | 2010 | 24 |
Why?
|
Descemet Membrane | 1 | 2011 | 3 |
Why?
|
Donor Selection | 1 | 2011 | 5 |
Why?
|
Pterygium | 1 | 2011 | 3 |
Why?
|
Keratoplasty, Penetrating | 1 | 2011 | 12 |
Why?
|
Endothelium, Corneal | 1 | 2011 | 6 |
Why?
|
Posterior Capsule of the Lens | 1 | 2011 | 1 |
Why?
|
Needlestick Injuries | 1 | 2011 | 3 |
Why?
|
Eye Injuries, Penetrating | 1 | 2011 | 6 |
Why?
|
Corneal Transplantation | 1 | 2011 | 10 |
Why?
|
Cataract Extraction | 1 | 2011 | 12 |
Why?
|
Ketorolac Tromethamine | 1 | 2011 | 1 |
Why?
|
Glucocorticoids | 2 | 2009 | 107 |
Why?
|
Cicatrix | 1 | 2011 | 28 |
Why?
|
Presbyopia | 1 | 2011 | 4 |
Why?
|
Electrocoagulation | 1 | 2011 | 12 |
Why?
|
Conjunctival Diseases | 1 | 2010 | 3 |
Why?
|
Corneal Perforation | 1 | 2010 | 1 |
Why?
|
Anterior Capsule of the Lens | 1 | 2010 | 1 |
Why?
|
Eye Injuries | 1 | 2010 | 9 |
Why?
|
Cyanoacrylates | 1 | 2010 | 4 |
Why?
|
Keratomileusis, Laser In Situ | 2 | 2010 | 6 |
Why?
|
Tissue Adhesives | 1 | 2010 | 9 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2010 | 1 |
Why?
|
Herpes Zoster Vaccine | 1 | 2010 | 3 |
Why?
|
Surgical Mesh | 1 | 2010 | 13 |
Why?
|
Hyperopia | 1 | 2010 | 8 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2010 | 1 |
Why?
|
Myopia, Degenerative | 1 | 2010 | 2 |
Why?
|
Corneal Ulcer | 1 | 2010 | 11 |
Why?
|
Corneal Opacity | 1 | 2010 | 3 |
Why?
|
Corneal Stroma | 1 | 2010 | 11 |
Why?
|
Amyloidosis | 1 | 2010 | 31 |
Why?
|
Cornea | 2 | 2010 | 36 |
Why?
|
Choroiditis | 1 | 2010 | 2 |
Why?
|
Fluocinolone Acetonide | 1 | 2009 | 3 |
Why?
|
Drug Implants | 1 | 2009 | 15 |
Why?
|
Myopia | 1 | 2010 | 14 |
Why?
|
Wound Healing | 1 | 2011 | 106 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 78 |
Why?
|
Papillomavirus Vaccines | 1 | 2010 | 19 |
Why?
|
Collagen | 1 | 2010 | 118 |
Why?
|
Nucleoside Transport Proteins | 1 | 2008 | 1 |
Why?
|
Receptor, Adenosine A2A | 1 | 2008 | 6 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 241 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2006 | 210 |
Why?
|
Uveal Neoplasms | 1 | 2007 | 3 |
Why?
|
Eye Enucleation | 1 | 2007 | 10 |
Why?
|
Tomography, Optical Coherence | 4 | 2010 | 10 |
Why?
|
Retina | 2 | 2008 | 60 |
Why?
|
Ophthalmology | 1 | 2006 | 13 |
Why?
|
User-Computer Interface | 1 | 2006 | 36 |
Why?
|
Humans | 17 | 2005 | 1856 |
Why?
|
Melanoma | 1 | 2007 | 87 |
Why?
|
Temporal Muscle | 1 | 2005 | 5 |
Why?
|
Postoperative Complications | 1 | 2010 | 305 |
Why?
|
Fascia | 1 | 2005 | 15 |
Why?
|
Gold | 1 | 2005 | 17 |
Why?
|
Eyelid Diseases | 1 | 2005 | 11 |
Why?
|
Foreign-Body Migration | 1 | 2005 | 20 |
Why?
|
Education, Medical | 1 | 2006 | 79 |
Why?
|
Neuroprotective Agents | 3 | 2007 | 60 |
Why?
|
Female | 9 | 2009 | 1643 |
Why?
|
Male | 13 | 2005 | 1553 |
Why?
|
Middle Aged | 7 | 2007 | 1161 |
Why?
|
Injections, Intravenous | 2 | 2009 | 105 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2006 | 36 |
Why?
|
Vaccination | 2 | 2010 | 92 |
Why?
|
Adult | 6 | 2005 | 1317 |
Why?
|
Rats, Sprague-Dawley | 5 | 2006 | 257 |
Why?
|
Follow-Up Studies | 2 | 2007 | 553 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2006 | 94 |
Why?
|
Drug Therapy, Combination | 2 | 2009 | 189 |
Why?
|
Intravitreal Injections | 1 | 2011 | 6 |
Why?
|
Xerophthalmia | 1 | 2011 | 2 |
Why?
|
Vitamin A Deficiency | 1 | 2011 | 2 |
Why?
|
Vitamin A | 1 | 2011 | 6 |
Why?
|
Macular Degeneration | 1 | 2011 | 10 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 15 |
Why?
|
Prednisolone | 1 | 2011 | 21 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2011 | 31 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 51 |
Why?
|
Microglia | 2 | 2008 | 29 |
Why?
|
Cnidarian Venoms | 1 | 2010 | 1 |
Why?
|
Keratoconjunctivitis | 1 | 2010 | 2 |
Why?
|
Acrylamides | 1 | 2010 | 3 |
Why?
|
Anthozoa | 1 | 2010 | 2 |
Why?
|
Metaplasia | 1 | 2010 | 18 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2010 | 3 |
Why?
|
Retinal Neurons | 1 | 2010 | 4 |
Why?
|
Anti-Allergic Agents | 1 | 2010 | 5 |
Why?
|
Iridectomy | 1 | 2010 | 1 |
Why?
|
Microscopy, Acoustic | 1 | 2010 | 4 |
Why?
|
Fundus Oculi | 1 | 2010 | 15 |
Why?
|
Anterior Eye Segment | 1 | 2010 | 4 |
Why?
|
Fluorescein Angiography | 1 | 2010 | 19 |
Why?
|
Androstadienes | 1 | 2010 | 25 |
Why?
|
Vision, Low | 1 | 2010 | 3 |
Why?
|
Lipopolysaccharides | 2 | 2008 | 98 |
Why?
|
Retinal Detachment | 1 | 2009 | 7 |
Why?
|
Vitreous Body | 1 | 2009 | 14 |
Why?
|
Polymers | 1 | 2010 | 60 |
Why?
|
Rats | 5 | 2006 | 530 |
Why?
|
Functional Laterality | 1 | 2010 | 50 |
Why?
|
Biopsy | 1 | 2010 | 207 |
Why?
|
Retinal Ganglion Cells | 2 | 2006 | 18 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 224 |
Why?
|
Visual Acuity | 1 | 2010 | 46 |
Why?
|
Oxidative Stress | 3 | 2006 | 119 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 39 |
Why?
|
Uveitis | 1 | 2008 | 5 |
Why?
|
Endotoxins | 1 | 2008 | 35 |
Why?
|
Salmonella enterica | 1 | 2008 | 1 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2008 | 1 |
Why?
|
Aged | 3 | 2007 | 988 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2008 | 5 |
Why?
|
Administration, Oral | 1 | 2009 | 170 |
Why?
|
Prednisone | 1 | 2009 | 80 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 191 |
Why?
|
Acute Disease | 1 | 2010 | 271 |
Why?
|
Epithelial Cells | 1 | 2010 | 135 |
Why?
|
Tetrahydrocannabinol | 1 | 2007 | 3 |
Why?
|
Recurrence | 1 | 2009 | 261 |
Why?
|
Fatal Outcome | 1 | 2007 | 86 |
Why?
|
Intraocular Pressure | 1 | 2007 | 22 |
Why?
|
Glaucoma | 1 | 2007 | 19 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2006 | 13 |
Why?
|
Blood-Retinal Barrier | 1 | 2006 | 1 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 431 |
Why?
|
Antihypertensive Agents | 1 | 2007 | 54 |
Why?
|
Diabetic Retinopathy | 1 | 2006 | 14 |
Why?
|
Young Adult | 1 | 2009 | 380 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 243 |
Why?
|
Facial Nerve Injuries | 1 | 2005 | 4 |
Why?
|
Blinking | 1 | 2005 | 11 |
Why?
|
Equipment Design | 1 | 2006 | 132 |
Why?
|
Eyelids | 1 | 2005 | 15 |
Why?
|
Suture Techniques | 1 | 2005 | 48 |
Why?
|
Reoperation | 1 | 2005 | 106 |
Why?
|
Child | 2 | 2010 | 749 |
Why?
|
Computer Simulation | 1 | 2006 | 134 |
Why?
|
Retrospective Studies | 1 | 2009 | 653 |
Why?
|
Animals | 6 | 2006 | 1031 |
Why?
|
Enzyme Activation | 3 | 2006 | 177 |
Why?
|
Cells, Cultured | 1 | 2008 | 447 |
Why?
|
Treatment Outcome | 1 | 2009 | 661 |
Why?
|
RNA, Messenger | 1 | 2008 | 394 |
Why?
|
Adolescent | 1 | 2010 | 891 |
Why?
|
Cell Death | 2 | 2008 | 94 |
Why?
|
Nitrosation | 1 | 2010 | 6 |
Why?
|
Contact Lenses, Hydrophilic | 1 | 2010 | 9 |
Why?
|
Caspase 3 | 1 | 2010 | 56 |
Why?
|
Cytoprotection | 1 | 2010 | 32 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 54 |
Why?
|
Peroxynitrous Acid | 1 | 2008 | 8 |
Why?
|
Disease Progression | 1 | 2011 | 244 |
Why?
|
Neuroglia | 1 | 2010 | 49 |
Why?
|
Superoxides | 1 | 2008 | 36 |
Why?
|
NADPH Oxidase | 1 | 2008 | 21 |
Why?
|
Injections | 1 | 2007 | 53 |
Why?
|
Nitric Oxide | 1 | 2008 | 85 |
Why?
|
Cell Count | 1 | 2007 | 163 |
Why?
|
Macrophages | 1 | 2008 | 148 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 216 |
Why?
|
Permeability | 1 | 2006 | 52 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 65 |
Why?
|
Retinal Vessels | 1 | 2006 | 17 |
Why?
|
Cell Survival | 1 | 2007 | 229 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 51 |
Why?
|
Blotting, Western | 1 | 2006 | 275 |
Why?
|
Models, Biological | 1 | 2008 | 410 |
Why?
|
Disease Models, Animal | 1 | 2007 | 349 |
Why?
|
Immunohistochemistry | 1 | 2006 | 355 |
Why?
|
Apoptosis | 1 | 2006 | 265 |
Why?
|
